A detailed history of Gamma Investing LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 862 shares of REPL stock, worth $10,947. This represents 0.0% of its overall portfolio holdings.

Number of Shares
862
Previous 464 85.78%
Holding current value
$10,947
Previous $4.18 Million 126.25%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$8.09 - $11.23 $3,219 - $4,469
398 Added 85.78%
862 $9.45 Million
Q2 2024

Jul 02, 2024

BUY
$5.01 - $9.46 $1,057 - $1,996
211 Added 83.4%
464 $4.18 Million
Q1 2024

Apr 05, 2024

BUY
$6.87 - $9.31 $1,374 - $1,862
200 Added 377.36%
253 $2.07 Million
Q4 2023

Feb 01, 2024

BUY
$6.75 - $16.18 $357 - $857
53 New
53 $411,000

Others Institutions Holding REPL

About Replimune Group, Inc.


  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $626M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.